ESR1 and breast carcinoma: Since ERα transcriptionally upregulated SLC7A11 and SLC3A2 expression (Fig. 4), we believe that estrogen/ERα inhibits ferroptosis mainly through the xc−-GPX4 axis in ER+ breast cancer.